1236 related articles for article (PubMed ID: 29555425)
1. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
[TBL] [Abstract][Full Text] [Related]
3. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.
Slooter AJ; Cruts M; Kalmijn S; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
Arch Neurol; 1998 Jul; 55(7):964-8. PubMed ID: 9678314
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Downregulation of APOE, Polymorphic Variations of APOE, Diet, Social Isolation, and Co-morbidities as Contributing Factors to Alzheimer's Disease: a Case-Control Study of Kashmiri Population.
Nissar K; Firdous P; Hussain A; Bashir S; Ahmad Z; Ganai BA
Mol Neurobiol; 2023 Oct; 60(10):5891-5901. PubMed ID: 37357229
[TBL] [Abstract][Full Text] [Related]
5. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
[TBL] [Abstract][Full Text] [Related]
6. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
[TBL] [Abstract][Full Text] [Related]
7. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
[TBL] [Abstract][Full Text] [Related]
8. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality.
Skoog I; Hesse C; Aevarsson O; Landahl S; Wahlström J; Fredman P; Blennow K
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):37-43. PubMed ID: 9436725
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
[TBL] [Abstract][Full Text] [Related]
10. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
[TBL] [Abstract][Full Text] [Related]
11. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
[TBL] [Abstract][Full Text] [Related]
12. The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE).
Wolters FJ; Yang Q; Biggs ML; Jakobsdottir J; Li S; Evans DS; Bis JC; Harris TB; Vasan RS; Zilhao NR; Ghanbari M; Ikram MA; Launer L; Psaty BM; Tranah GJ; Kulminski AM; Gudnason V; Seshadri S;
PLoS One; 2019; 14(7):e0219668. PubMed ID: 31356640
[TBL] [Abstract][Full Text] [Related]
13. HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study.
Alizadeh BZ; Njajou OT; Millán MR; Hofman A; Breteler MM; van Duijn CM
Neurobiol Aging; 2009 Feb; 30(2):330-2. PubMed ID: 17628213
[TBL] [Abstract][Full Text] [Related]
14. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
[TBL] [Abstract][Full Text] [Related]
15. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
[TBL] [Abstract][Full Text] [Related]
16. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
[TBL] [Abstract][Full Text] [Related]
17. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.
Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA
Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502
[TBL] [Abstract][Full Text] [Related]
18. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
[TBL] [Abstract][Full Text] [Related]
19. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.
Souza DR; de Godoy MR; Hotta J; Tajara EH; Brandão AC; Pinheiro Júnior S; Tognola WA; dos Santos JE
Braz J Med Biol Res; 2003 Jul; 36(7):919-23. PubMed ID: 12845379
[TBL] [Abstract][Full Text] [Related]
20. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
Blue EE; Cheng A; Chen S; Yu CE;
JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
